CPBTD
DGX icon

Central Pacific Bank - Trust Division’s Quest Diagnostics DGX Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
1,607
+102
+7% +$20K 0.03% 370
2026
Q1 		$295K Buy
1,505
+6
+0.4% +$1.17K 0.04% 382
2025
Q4 		$260K Buy
+1,499
New +$273K 0.03% 397

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Central Pacific Bank - Trust Division's DGX Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Quest Diagnostics (DGX) stake by 6.8% in Q2 2026, buying an estimated $20K and bringing the position to 1,607 shares worth $341K. The position accounts for 0.03% of the portfolio, ranked #370.

Central Pacific Bank - Trust Division first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 678 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Central Pacific Bank - Trust Division held 1,607 shares of Quest Diagnostics worth $341K as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 102 Quest Diagnostics shares in Q2 2026, an estimated $20K.
  • Quest Diagnostics made up 0.03% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #370 holding.
  • Central Pacific Bank - Trust Division first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 678 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.